David R. Liu Profile Banner
David R. Liu Profile
David R. Liu

@davidrliu

Followers
64,155
Following
59
Media
582
Statuses
3,326

Professor at Harvard, Broad Institute, & HHMI. Our lab integrates chemistry & evolution to illuminate biology & enable new therapeutics. IG/Threads: @davidrliu1

Massachusetts, USA
Joined November 2008
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@davidrliu
David R. Liu
2 months
Today in @Science_Magazine we report the laboratory evolution of compact degrons that enable targeted protein degradation triggered by an otherwise-inert small molecule, a multidisciplinary study that integrates organic chemistry, molecular glues, protein evolution, genome…
Tweet media one
16
287
1K
@davidrliu
David R. Liu
4 years
Study of 206 monoclonal antibodies against #SARSCoV2 isolated from 8 #COVID19 patients. Some antibody clones are highly effective at neutralizing live SARS-CoV-2 virus in cells, suggesting that we now know human antibody sequences that would be effective COVID-19 drugs. (1/2)
Tweet media one
94
3K
6K
@davidrliu
David R. Liu
2 years
Graduate school.
40
377
3K
@davidrliu
David R. Liu
1 year
Alyssa, a 13-year old T-cell leukemia (ALL) patient in the UK, was the first person to receive a base editing therapeutic—T cells with three base edits—and the first patient reported to benefit from base editing: complete remission, 6 months later. 1/3
49
810
3K
@davidrliu
David R. Liu
2 years
Today we report in @CellCellPress an engineered virus-like particle (eVLP) platform that mediates efficient in vivo delivery of therapeutic proteins, including base editors and Cas9 nuclease, resulting in therapeutic editing in multiple mouse organs. 1/14
Tweet media one
29
562
3K
@davidrliu
David R. Liu
5 years
Today we describe prime editing, a very versatile new approach to genome editing in human cells without cutting the DNA double helix. We integrated a reverse transcriptase with a disabled CRISPR enzyme to copy virtually any edit from an engineered guide RNA into a target site...
39
902
2K
@davidrliu
David R. Liu
3 years
Today we report in @Nature a base editing strategy that efficiently corrects the mutation in the β-globin gene HBB that causes sickle cell disease (SCD), the most common deadly genetic disorder, rescuing the disease in mice. 1/11
32
529
2K
@davidrliu
David R. Liu
1 year
Today we report in @ScienceMagazine a one-time base editing treatment for Spinal Muscular Atrophy (SMA), the leading genetic cause of infant mortality worldwide, affecting ~1 in 10,000 births. PDF: 1/17
Tweet media one
33
505
2K
@davidrliu
David R. Liu
3 years
Today we report the use of base editing in patient-derived cells and in mice to correct the most common cause of progeria, the devastating rapid aging disease. Progeria is typically caused by a dominant negative C•G-to-T•A point mutation in LMNA. 1/11
Tweet media one
35
515
2K
@davidrliu
David R. Liu
1 year
Science educators searching for a compelling way to teach the importance of understanding how small molecules, macromolecules, and macromolecular assemblies differ: your quest is at an end.
Tweet media one
78
225
2K
@davidrliu
David R. Liu
10 months
Three of the more costly and frequently used reagents in molecular biology are rolling circle amplification (RCA) mix, chemically competent MachOne (or other E. coli) cells, and Gibson assembly mix. Postdoc Julian Willis—who is starting his own lab in the UK soon—developed…
35
511
2K
@davidrliu
David R. Liu
4 years
Today we report in @nature , in collaboration with the labs of Joseph Mougous and @VamsiMootha , the development of a new class of CRISPR-free base editors that enable precision editing of mitochondrial DNA (mtDNA) for the first time. 1/7
29
476
2K
@davidrliu
David R. Liu
6 months
In a major milestone for science, for medicine, and for patients, the world’s first CRISPR drug has been approved in the UK. “A new treatment for sickle-cell disease and transfusion-dependent β-thalassemia has been authorised by the Medicines and Healthcare products Regulatory…
24
345
2K
@davidrliu
David R. Liu
2 years
Every day I pinch myself for having the opportunity to work with such talented and hard-working undergraduates, graduate students, postdocs, and collaborators. I’m grateful to @theNASciences for recognizing their creativity and tireless determination.🙏
@theNASciences
National Academy of Sciences
2 years
David R. Liu of @BroadInstitute is being inducted as a member of the National Academy of Sciences for pioneering research integrating chemistry, evolution, and engineering into genome editing and chemical biology. Watch the #NAS159 livestream:
Tweet media one
13
25
624
71
36
1K
@davidrliu
David R. Liu
1 year
Today we report in @NatureMedicine a study led by Christine & Jonathan Seidman’s lab in which we used adenine base editing in vivo to correct a common mutation that causes hypertrophic cardiomyopathy (HCM), a disease that occurs in ~1 in 500 people (1/8)
Tweet media one
23
256
1K
@davidrliu
David R. Liu
3 years
Working with an incredibly dedicated and talented group of students, postdocs, and collaborators has been the honor of my professional life. I'm grateful that their hard work and insights have been recognized by my election to the National Academy of Sciences.🙏 @theNASciences
@HarvardCCB
Harvard Chemistry
3 years
Congratulations to @davidrliu , one 120 new members elected into @theNASEM ! Liu is recognized, in part, for inventing base editing, a tool that can edit the genomes of living cells with unprecedented precision. Browse the new members:
Tweet media one
6
25
321
70
37
1K
@davidrliu
David R. Liu
4 years
Promising new preprint from UK+US researchers showing that a single injection of the Oxford adenovirus that encodes the #COVID19 #SARSCoV2 spike protein (ChAdOx1) serves as an effective vaccine in monkeys, blocking pneumonia & greatly lowering viral load.👏
Tweet media one
31
459
1K
@davidrliu
David R. Liu
4 years
Science is not political. It is not an opponent who can be defeated. Science is simply a philosophy that considers all ideas but moves forward those supported by the best evidence. Battling science is like battling gravity. Doing so during a pandemic is deadly & self-destructive.
Tweet media one
62
242
1K
@davidrliu
David R. Liu
3 years
Learned to weld during the pandemic, then made this unconventional bonsai pot from a stone, steel chain, welding stick, epoxy putty, petrified wood, resin, and paint. Inspired by brutalist chain art and the floating wine bottle illusion. Build photos below 👇🏻
34
40
1K
@davidrliu
David R. Liu
4 years
I'm humbled to be elected to the National Academy of Medicine in recognition of the remarkable dedication and talents of our students and postdocs, past and present. Congratulations to all in the @liugroup , and to the 99 other new members @theNAMedicine !
@theNAMedicine
National Academy of Medicine
4 years
Congratulations and welcome to the 100 new members elected today to the National Academy of Medicine!
Tweet media one
6
48
204
49
31
1K
@davidrliu
David R. Liu
1 year
Today we report in @NatureBiotech the development of dual-AAV in vivo delivery systems for prime editors that can support efficient prime editing in multiple organs such as brain, liver, and heart. 1/4
Tweet media one
12
232
1K
@davidrliu
David R. Liu
4 months
Today we report in @NatureBiotech an engineered virus-like particle system for in vivo delivery of prime editor protein-RNA complexes. This PE-eVLP platform can support therapeutic prime editing in animal models of genetic disease. /1
Tweet media one
13
195
1K
@davidrliu
David R. Liu
2 years
Here are the #Omicron #SARSCoV2 mutations in each gene and the drugs, candidates, & vaccines that target them. The 3CL protease and RNA polymerase have only 1 mutation each (unlike spike, which has >30); the drug candidates targeting them might be more likely to retain efficacy.
Tweet media one
52
353
1K
@davidrliu
David R. Liu
1 year
Rest in peace, Orion (2003-2023). Thank you for 20 years of love, warmth, and snarkiness. 🙏
Tweet media one
24
6
996
@davidrliu
David R. Liu
2 years
Experimentalists who also have machine learning skills.
11
108
962
@davidrliu
David R. Liu
1 year
Urging prosecution of a public health official who works tirelessly to provide the public lifesaving advice during a pandemic based on the best science available to date suggests you identify as Uninformed/Gullible, @elonmusk . Please use your intellect & resources to do better.
Tweet media one
50
93
943
@davidrliu
David R. Liu
2 years
Three years in the making—and twice postponed—my trip to Africa was breathtaking, inspiring, and humbling. Africa is full of color, texture, energy, and warmth unlike anything I experienced before. Here are photos and brief recounts. (All animals in these images are wild). 1/36
Tweet media one
Tweet media two
Tweet media three
Tweet media four
47
56
956
@davidrliu
David R. Liu
2 years
Wow. “4 genes were knocked out…including one that encodes a molecule that causes an aggressive human rejection response. A growth gene was also inactivated to prevent the pig’s heart from continuing to grow…6 human genes were inserted…to make the porcine organs more tolerable”
@nytimes
The New York Times
2 years
For the first time, surgeons have successfully transplanted a genetically altered pig’s heart into a patient. The procedure may bring new hope to hundreds of thousands of people with organ failure.
116
562
2K
12
151
905
@davidrliu
David R. Liu
4 years
It’s wonderful to see Jennifer and Emmanuelle recognized with the 2020 Nobel Prize in chemistry. The seminal “Jinek et al.” paper they published together has been cited >9,500 times—approximately once every 8 hours since its publication in 2012. (1/3)
2
107
908
@davidrliu
David R. Liu
1 year
Today we share in @NatureRevGenet a review of prime editing for precise and versatile genome manipulation. The review covers current prime editing strategies, limitations, recent developments, and applications, including work from 148 publications. 1/5
Tweet media one
6
224
841
@davidrliu
David R. Liu
4 years
@TruthHurts_DJT @chrislhayes Yes, very good news. There are now multiple reports of monoclonal (we know exactly which protein sequence needs to be manufactured) human (should be quite safe as drugs) antibodies that block the #SARSCoV2 virus that causes #COVID19 . Same strategy as was used to treat Ebola.
22
228
821
@davidrliu
David R. Liu
8 months
Today we report in @CellCellPress a suite of engineered and PACE-evolved prime editor variants PE6a-g. These new prime editors improve the activity, in vivo deliverability, and in vivo editing efficiency of prime editing. PDF: (1/15)
Tweet media one
9
205
844
@davidrliu
David R. Liu
4 years
Itching to read a 21-page review article (plus 16-page Supplement) on CRISPR nucleases, base editors, transposases, and prime editors with 454 total references? It's your lucky day. Congrats, Andrew and Luke! Review article: SI:
Tweet media one
Tweet media two
Tweet media three
Tweet media four
9
248
821
@davidrliu
David R. Liu
2 years
I’m humbled and grateful that the work of our students and collaborators has been recognized with this award. 🙏 Also, I found out via Twitter just now.
@KingFaisalPrize
King Faisal Prize جائزة الملك فيصل
2 years
Congratulations to “Professor David Ruchien Liu”, laureate of the 2022 #KingFaisalPrize in Medicine, focused on “Gene Editing Technologies”.
Tweet media one
2
30
135
60
35
808
@davidrliu
David R. Liu
4 years
Encouraging news for #COVID19 vaccines: preprint shows inactivated #SARSCoV2 virus injected into rodents & monkeys induces neutralizing antibodies against 10 representative SARS-CoV-2 strains & provides protection from live virus in monkeys, w/o AME/ADE.
Tweet media one
16
287
781
@davidrliu
David R. Liu
4 years
Simple proposal for the next two presidential debates: when one candidate is answering the moderator’s question, turn off the other candidate’s mic.
23
58
793
@davidrliu
David R. Liu
10 months
Today we report in @NatureGenet a study led by the team of @JonathanYenPhD and Mitch Weiss @StJude that characterizes Cas9 nuclease and adenine base editing strategies to induce fetal hemoglobin expression, clinical approaches to treat sickle-cell disease & beta-thalassemia. 1/10
Tweet media one
11
175
778
@davidrliu
David R. Liu
2 years
Today we report in @natBME the development of a suite of adenine based editors (ABEs) that are small enough to each fit, together with a guide RNA & all needed regulatory elements, into a single AAV to support efficient base editing in animals. 1/4
Tweet media one
11
145
738
@davidrliu
David R. Liu
4 years
Congratulations to Emmanuelle and Jennifer!
@NobelPrize
The Nobel Prize
4 years
BREAKING NEWS: The 2020 #NobelPrize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing.”
Tweet media one
729
25K
49K
2
43
743
@davidrliu
David R. Liu
2 years
Today we report in @NatureBiotech the phage-assisted continuous evolution (PACE) of all-protein, CRISPR-free base editors to enhance their efficiency and expand their targeting scope for mitochondrial and nuclear base editing.(1/8)
12
157
740
@davidrliu
David R. Liu
6 months
Our lab as well as students in the class I teach this semester enjoyed tasting the first CRISPR-edited salad greens, in which the myrosinase gene that results in the pungency of raw mustard greens (Brassica juncea) has been disabled, yielding a nutrient-dense, tasty, and…
Tweet media one
Tweet media two
18
74
735
@davidrliu
David R. Liu
4 years
It is hard to imagine 274 characters more damaging to US efforts to provide medicines for #COVID19 patients, and to provide vaccines for all of us. Sowing distrust of those who work tirelessly to ensure the safety and efficacy of our medicines and vaccines will kill Americans.
@realDonaldTrump
Donald J. Trump
4 years
The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the vaccines and therapeutics. Obviously, they are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives! @SteveFDA
30K
15K
62K
10
169
718
@davidrliu
David R. Liu
3 years
Today we report in @NatureProtocols detailed procedures for how to design and execute base editing experiments in mammalian cells, with many design steps also applicable to other cell types. Congrats Greg Newby and Tony Huang!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
6
170
727
@davidrliu
David R. Liu
1 year
Today we report in @natBME ex vivo prime editing of blood stem cells from sickle cell disease (SCD) patients, followed by transplantation into mice, correcting the SCD mutation to wild-type hemoglobin and rescuing SCD blood abnormalities. 1/12
Tweet media one
11
172
711
@davidrliu
David R. Liu
4 years
Updated #COVID19 #SARSCoV2 case timeline, with references cited and other improvements. PDF with embedded links to each reference can be downloaded here:
Tweet media one
@davidrliu
David R. Liu
4 years
#COVID19 case timeline I've been updating to keep an approximate order of events straight in my head. The case timeline can be useful when thinking about different types of #SARSCoV2 testing, quarantine timing, and other mitigation measures. Comments & corrections are welcome.
Tweet media one
12
175
412
17
375
701
@davidrliu
David R. Liu
4 years
Let’s estimate the total # of people in the US who have been infected by #COVID19 #SARSCoV2 as of Apr 4, and the number of US fatalities that will result from these infections. To avoid testing coverage uncertainty, we will use fatality data, rather than positive test data. (1/9)
32
264
704
@davidrliu
David R. Liu
4 years
RT-LAMP test for #COVID19 #SARSCoV2 from Brian Rabe and Connie Cepko: 30 min, requires a 65 °C bath (does not require a PCR machine or other specialized equipment), can detect 1 viral RNA copy per µL, works on saliva, readout is color change.
Tweet media one
6
278
692
@davidrliu
David R. Liu
2 years
Today we report in @biorxivpreprint twin prime editing, a variant of prime editing that enables in human cells targeted large DNA deletion and replacement, as well as gene-sized integration and inversion when combined with site-specific recombinases. 1/9
8
181
681
@davidrliu
David R. Liu
10 months
Happy to host Yale undergraduate science major (and reigning Olympic figure skating champion / 3x world champion) @nathanwchen & Professor @jennkwanMDPhD in our lab for a week of experiments, data analysis, and outreach activities. Thank you @IPWitte for showing Nathan the ropes.
Tweet media one
9
92
667
@davidrliu
David R. Liu
3 years
Today we report in @ScienceMagazine the development of a continuous evolution system that can reprogram a family of clinically used proteases to selectively cleave protein targets of our choosing. 1/10
5
142
669
@davidrliu
David R. Liu
1 year
Today we report in @NatureBiotech the conversion of adenine base editors (ABE) into next-generation cytosine base editors (TadCBEs) with high on-target activity and reduced off-target activity using phage-assisted continuous evolution (PACE). 1/14
Tweet media one
8
144
652
@davidrliu
David R. Liu
4 years
So true. Most new group members are surprised (and somewhat relieved) to learn that the vast majority of our experiments fail, even though most projects eventually succeed. The essence of experimental science is observing, carefully analyzing, and learning from repeated failure.
@NaturePortfolio
Nature Portfolio
4 years
“Failure is something that all scientists experience — but it’s hard to tell, looking at our shiny conferences, polished presentations and glossy journals.”
21
595
1K
7
145
653
@davidrliu
David R. Liu
2 years
A while ago I had a dream about an exoplanet landscape, complete with alien vegetation and floating land masses (thank you, Avatar). Today I finished this art project. Build details below. 1/3
19
27
630
@davidrliu
David R. Liu
4 years
A key piece of the #COVID19 #SARSCoV2 origin puzzle emerges: where did the virus's unusual spike protein RBD—the receptor-binding domain that engages human ACE2 protein and allows the virus to enter human cells—come from? A new study from Shen & coworkers provides an answer.(1/5)
Tweet media one
16
313
619
@davidrliu
David R. Liu
11 months
Early in my academic career I was invited to give a seminar. It was before we had published much, so I was asked to give a talk on our lab’s research plans. Three people total showed up…but two left during my talk. I felt sorry for the last one, who must have felt so trapped.😂
@Dr_Joe_Newman
Joe Newman
11 months
A career low point this evening. I was the “guest speaker” at a seminar. Attendance: zero. ZERO Literally no one. 😢 But on reflection, that’s less awkward than one person turning up. 😂 I helped myself to wine and kept quiet - no one needs to ever know about this… 🤫
418
139
8K
21
38
630
@davidrliu
David R. Liu
2 years
Excited (and a bit nervous 😅) to give a seminar tomorrow at 4 pm to the home crowd @broadinstitute and @ChemistryMIT . Zoom link:
Tweet media one
12
67
622
@davidrliu
David R. Liu
2 months
Today we report in @NatureComms the development of laboratory-evolved CBE6 cytosine base editors that offer high on-target C•G-to-T•A editing, virtually no A•T-to-G•C editing, low off-target editing, broad sequence context compatibility, and compatibility with multiple Cas…
Tweet media one
12
121
626
@davidrliu
David R. Liu
2 years
From the remarkable @ShannonDowney .
Tweet media one
6
83
617
@davidrliu
David R. Liu
3 years
For those planning to hold their next Zoom meeting at the #FourSeasons ...Total Landscaping parking lot, here is an up-rezzed photo suitable for use as a Zoom background. Edited to fix issues in the original photo from @ratemyskyperoom ; not to be used for documentary purposes.
Tweet media one
14
64
610
@davidrliu
David R. Liu
8 months
The first dosing of a patient in the U.S. with a base-edited therapeutic has taken place. Congratulations to the @BeamTx team on achieving this milestone. 🍻
@NicoleGaudelli
Nicole M. Gaudelli
8 months
First patient dosed with Beam-201! 💫
10
47
327
8
81
603
@davidrliu
David R. Liu
4 years
In addition, the authors observed interesting cross-reactivity of antibodies against SARS-CoV & MERS-CoV trimeric spike protein, but not against SARS-CoV & MERS-CoV spike receptor-binding domain, suggesting unusual antibody response viral specificity (2/2)
Tweet media one
9
211
559
@davidrliu
David R. Liu
4 years
As serological assays begin to identify people with presumed immunity to #COVID19 #SARSCoV2 —the first who will restore our societies—understanding antibody response timing is critical. This study of 173 patients suggests ~15 days to robust IgM/IgG levels.
Tweet media one
11
286
558
@davidrliu
David R. Liu
3 years
A thread: Many talented scientists including Alexis Komor and @NicoleGaudelli worked tirelessly starting in 2013 to develop and apply cytosine and adenine base editors, systems that directly edit targeted DNA base pairs in living cells without cutting the DNA double helix./1
Tweet media one
7
117
556
@davidrliu
David R. Liu
3 years
Today we report in @CellCellPress our new PE4max and PE5max prime editing systems that we first presented at @CSHLmeetings in August. 1/12
Tweet media one
11
153
549
@davidrliu
David R. Liu
3 years
More encouraging data on #COVID19 #SARSCoV2 mRNA vaccines, but antibody and T-cell response data suggest that it takes ~6-8 wks from first dose to full protection. People are mistakenly envisioning return to normal as soon as a vaccine is in hand. Don't fumble on the 1-yard line!
@EricTopol
Eric Topol
3 years
Very reassuring strength and durability of the #SARSVoV2 immune response from an mRNA ( @moderna_tx ) vaccine across the ages and through 4 months @NEJM today @NIAIDNews @NIH
Tweet media one
Tweet media two
20
296
872
12
272
546
@davidrliu
David R. Liu
1 year
Science and bonsai: two endeavors where obsessiveness has a home.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
13
15
543
@davidrliu
David R. Liu
4 years
We report RNA base editors that enable targeted conversion of A to m6A in endogenous RNAs in human cells in @NatureBiotech today. We used nuclear-localized dCas13 fused to a truncated METTL3 methyltransferase to achieve high-specificity A>m6A editing. 1/2
Tweet media one
4
153
529
@davidrliu
David R. Liu
1 month
An exciting new report in @NatureBiotech from @WangXiaoLab ’s team led by @HongyuChenChem shows that mRNAs with branched poly-A tails yield much higher levels, and prolonged production, of the corresponding proteins compared with conventional single-tailed mRNA. This discovery…
@WangXiaoLab
Xiao Wang
1 month
Why can RNA only be linear or circular? It can be branched! We made multi-tailed mRNA, and we had fun! Here is our story led by brilliant graduate student @HongyuChenChem : and his cartoon illustration👇 @ChemistryMIT @broadinstitute
Tweet media one
19
227
1K
3
79
532
@davidrliu
David R. Liu
2 years
Today we report in @NatureBiotech the high-throughout phase-assisted continuous evolution of compact Cas9 variants that require only single-nucleotide pyrimidine PAM sequences (N4TN and N4CN). This work was a terrific collaboration with @MoKhalilLab . 1/8)
Tweet media one
4
94
520
@davidrliu
David R. Liu
3 years
Today we report in @NatureBiotech part 1 of our new prime editing systems. We show that degraded pegRNAs poison prime editing. We developed engineered pegRNAs (epegRNAs) that stabilize the 3' extension and enhance PE efficiencies in 5 human cell types. 1/2
Tweet media one
Tweet media two
Tweet media three
Tweet media four
4
112
506
@davidrliu
David R. Liu
4 years
Can recovered #COVID19 patients be reinfected? In a study in rhesus macaques, the answer is NO, fortunately. "Monkeys with re-exposure showed no recurrence of COVID-19". Let's hope immunity is long-lasting and difficult to overcome by #coronavirus mutation
13
219
503
@davidrliu
David R. Liu
1 year
Today we report in @NatureComms the development of compact zinc-finger base editors that edit mitochondrial or nuclear DNA in human cells and in animals, building on our previous development of TALE BEs that enabled the first precise editing of mtDNA. 1/8
Tweet media one
5
100
494
@davidrliu
David R. Liu
3 years
These impressive results from Gilmore et al. show that gene editing technologies, mRNA engineering & manufacturing, and in vivo delivery can already come together into one-time treatments that offer new hope for patients suffering from genetic diseases.👏
@kiranmusunuru
Kiran Musunuru
3 years
A milestone in modern medicine: 1st therapeutic in vivo gene editing in human patients! From Julian Gillmore, @intelliatweets & colleagues out today @NEJM : Here’s an overview of a new potential treatment for transthyretin (ATTR) amyloidosis. (thread)
Tweet media one
18
466
1K
4
95
471
@davidrliu
David R. Liu
3 years
Pfizer presents data showing that a third dose of their #COVID19 mRNA vaccine elicits much higher neutralizing serum titers against canonical, beta, and delta #SARSCoV2 strains. (And Pfizer's strategy for mRNA therapeutics includes base editing!—slide 22)
Tweet media one
Tweet media two
Tweet media three
Tweet media four
9
117
471
@davidrliu
David R. Liu
10 months
Be inspired in 15 minutes: @SammyBasso , the world's oldest living progeria patient, explains how he maintains such a positive life philosophy, working with us every week to advance a gene editing treatment towards the clinic. Video: @BrilliantMindsSthlm
Tweet media one
9
75
460
@davidrliu
David R. Liu
4 years
@Rkaycue To be clear, the study I summarized above and the preprint article I linked was not done by my lab—by “we” I mean “humanity”. We all should be grateful to the #COVID19 researchers who have worked around the clock over the past few months to make stunning progress in little time.
4
33
449
@davidrliu
David R. Liu
4 years
Exploiting the pandemic to wall off the U.S. and dismantle one of our greatest strengths—our ability to attract and retain the brightest minds from around the world—may ultimately cause even more long-term, self-inflicted damage to our country than #COVID19 . Abhorrent.
@sahilkapur
Sahil Kapur
4 years
ICE is telling international students on F-1 and M-1 visas that if their school is doing online-only courses they must leave the country or transfer to a place with in-person instruction—or they'll be deemed in the US illegally and subject to deportation.
280
2K
2K
10
117
458
@davidrliu
David R. Liu
6 months
The first in vivo base editing clinical trial outcomes are now reported, following last year’s positive ex vivo base editing clinical outcomes! Congratulations to @kiranmusunuru , @skathire , @ambellinger , @NicoleGaudelli , & other scientists at @VerveTx and @BeamTx on these…
@kiranmusunuru
Kiran Musunuru
6 months
The culmination of 10+ years of work to use #CRISPR gene editing to fight heart disease! @ambellinger @VerveTx $VERV presenting the interim data from the ongoing heart-1 Phase 1b clinical trial of VERVE-101 base editing for HeFH patients, at #AHA23 now. Let’s start! 🧵
Tweet media one
7
63
332
6
55
459
@davidrliu
David R. Liu
7 months
Today we report in @nchembio a collaboration led by Haoxin Li in Ben Cravatt's lab to illuminate functional and druggable cysteines in the human proteome by integrated base editing and activity-based protein profiling. PDF:
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
97
449
@davidrliu
David R. Liu
4 years
Early advice that “masks are not effective” against #COVID may end up being the second-worst misstep of our pandemic response, as it eroded credibility & sowed distrust. The worst might be politicizing mask wearing even after all the data shows it is key.
16
141
436
@davidrliu
David R. Liu
4 years
First in vivo CRISPR-mediated genome editing in human patients has begun, in this case to treat a genetic blindness. The age of human genome editing continues to advance.
3
158
432
@davidrliu
David R. Liu
4 years
#CRISPR jack-o-lanterns. Photo sent to me by @Yeastdoc1 . Looks like the carvings were done at @uofg .
Tweet media one
4
57
433
@davidrliu
David R. Liu
4 years
New study from Ueki et al. with live airborne #SARSCoV2 virus confirms 1) Masks worn by infected ppl reduce #coronavirus transmission. 2) Masks worn by healthy ppl protect themselves from infection. 3) N95 mask>surgical>cloth>no mask (1/2) Note log scales.
Tweet media one
17
198
430
@davidrliu
David R. Liu
4 years
#COVID19 case timeline I've been updating to keep an approximate order of events straight in my head. The case timeline can be useful when thinking about different types of #SARSCoV2 testing, quarantine timing, and other mitigation measures. Comments & corrections are welcome.
Tweet media one
12
175
412
@davidrliu
David R. Liu
4 years
2015 paper showing how a Chinese bat #Coronavirus recombined with a SARS-CoV can use ACE2 to efficiently enter human airway cells and replicate, suggesting “a potential risk of SARS-CoV re-emergence from viruses currently circulating in bat populations.”
8
191
406
@davidrliu
David R. Liu
2 years
The first human patients have been treated with base edited cells in an academic clinical trial in the UK led by Professor Waseem Qasim @ucl . Allogeneic CAR-T cells containing multiple base edits are infused to treat relapsed or refractory T-cell leukemia.
12
77
412
@davidrliu
David R. Liu
2 years
Precise gene correction with base editing & prime editing, in vivo delivery of gene therapies, CRISPR-based diagnostics, complete genome sequencing, experimental & computational protein structure solving, & spatial transcriptomics are 6 of 7 techs to watch for 2022 from @Nature .
@Nature
nature
2 years
Seven technologies set to shake up science in 2022
9
181
497
4
75
412
@davidrliu
David R. Liu
4 years
We report AAV-mediated in vivo base editing (CBE and ABE) of brain, liver, retina, heart, & skeletal muscle, along with partial rescue of a neurodegenerative ataxia mouse model. Congrats to Jon, Ariel, Nachiket, Jessie, Erin, Rossano, Luke, Jason, and Qin!
5
128
408
@davidrliu
David R. Liu
3 years
We leave a basket of packaged snacks on a porch table for delivery drivers. An unemployed squirrel also uses this basket, which is actually ok because the squirrel & our drivers have complementary tastes. The squirrel drags away quality snacks with nuts, but tosses all raisins.😂
Tweet media one
Tweet media two
14
20
402
@davidrliu
David R. Liu
2 years
This could be the first war lost & won by social media-enabled real-time: 1) Situational awareness 2) Strategic requests, foreign policy updates, & PR from a head-of-state ( @ZelenskyyUa ) 3) Public pressure that rapidly shapes key multinational decisions. I think Putin may lose.
Tweet media one
17
28
400
@davidrliu
David R. Liu
3 years
Henry Kim and coworkers report the use of in vivo prime editing in the eye to treat a genetic blindness and in the liver to treat a metabolic disease, achieving disease rescue in both cases with no detected off-target prime editing.
@natBME
Nature Biomedical Engineering
3 years
Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases
Tweet media one
Tweet media two
4
58
225
4
83
398
@davidrliu
David R. Liu
2 years
Today we share in @CellCellPress a new review of current in vivo delivery technologies that have enabled therapeutic in vivo gene editing—including viral vector, lipid nanoparticle (LNP), and virus-like particle (VLP) methods—and application examples. 1/2
10
91
394
@davidrliu
David R. Liu
4 years
Springer-Nature announces that Nature and most Nature-family journals are joining open access (Plan S). No details yet on how, or at what cost, but this decision substantially advances #openaccess for scientific research publications.
7
102
390
@davidrliu
David R. Liu
2 years
Today we report in @NatureComms the evolution of functionalized DNA polymers that bind a target molecule, and the use of machine learning to generate novel polymer sequences that bind the target—but are unrelated to any of the experimental sequences. 1/6
Tweet media one
9
59
387
@davidrliu
David R. Liu
2 years
Today we share in @NatureProtocols detailed strategy and experimental procedures for designing and executing prime editing (and twinPE) experiments in mammalian cells. Congrats Jordan, @AlexanderASousa , Peyton, and @PeterJ_Chen for this thorough analysis.
Tweet media one
7
83
385
@davidrliu
David R. Liu
3 years
Today we report in @NatureComms the development of periplasmic phage-assisted continuous evolution (pPACE). PACE greatly accelerates laboratory protein evolution, but was previously limited to the E. coli cytosol, which does not support disulfide bonds.1/2
Tweet media one
Tweet media two
Tweet media three
Tweet media four
5
76
382
@davidrliu
David R. Liu
2 years
2022 looking like 1939.
@petergyang
Peter Yang
2 years
Video of Ukrainian father saying goodbye to his kids while he stays behind to fight. Fuck war.
5K
47K
205K
15
52
375
@davidrliu
David R. Liu
1 year
Alyssa's leukemia went into remission by 1 month, and is clear 6 months later🤞. 9 more patients to follow. Much gratitude to Alyssa & her family, Waseem's team, Alexis Komor ( @KomorLab ) who led the development of CBE as a postdoc in our lab, & many others who paved this path.3/3
Tweet media one
10
35
370
@davidrliu
David R. Liu
3 years
Today we report the evolution of sortase A, which normally cuts & pastes proteins at LPXTG, to instead operate on LMVGG, found in amyloid beta. Evolved sortase can label endogenous ABeta in CSF for detection & can modify ABeta to impede its aggregation.1/2
Tweet media one
4
72
373
@davidrliu
David R. Liu
3 years
Too real 😱
@s_m_aguillon
Dr. Stepfanie Aguillon 😷
3 years
The scariest of pumpkins for our lab nightmares display… the -80 freezer meltdown 🎃
50
576
5K
4
30
372